Twelve-month outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration: Data from an observational study

M.C. Gillies, V. Nguyen, V. Daien, J.J. Arnold, Nigel Morlet, D. Barthelmes

Research output: Contribution to journalArticlepeer-review

55 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Twelve-month outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration: Data from an observational study'. Together they form a unique fingerprint.

Nursing and Health Professions